A phase 3 randomised double-blind parallel group 24 week study to evaluate efficacy and sagety of once daily empagliflozin 10mg and 25mg compared to placebo all administed as oral fixed dose

  • Simpson, Richard (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date15/04/13 → 20/02/14

Clinical Trial Phase

  • Phase III (a & b)